Long-term effects of intensive glucose lowering on cardiovascular outcomes (Q33851861)

29 July 2017

Long-term effects of intensive glucose lowering on cardiovascular outcomes (English)

1 reference

29 July 2017

0 references

1 reference

Hertzel C Gerstein

2

0 references

John Buse

object named as

John B Buse

6

0 references

Faramarz Ismail-Beigi

5

object named as

Faramarz Ismail-Beigi

1 reference

29 July 2017

1

ACCORD Study Group

1 reference

29 July 2017

7

David C Goff

1 reference

29 July 2017

15

William T Friedewald

1 reference

29 July 2017

Jeffrey L Probstfield

8

object named as

Jeffrey L Probstfield

1 reference

29 July 2017

Michael E Miller

3

1 reference

29 July 2017

Saul Genuth

4

1 reference

29 July 2017

William C Cushman

9

1 reference

29 July 2017

Henry N Ginsberg

10

1 reference

29 July 2017

J Thomas Bigger

11

1 reference

29 July 2017

Richard H Grimm

12

1 reference

29 July 2017

Robert P Byington

13

1 reference

29 July 2017

Yves D Rosenberg

14

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

The New England Journal of Medicine

29 July 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

364

1 reference

29 July 2017

9

1 reference

29 July 2017

818-828

1 reference

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Effects of combination lipid therapy in type 2 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Effects of intensive blood-pressure control in type 2 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

10-year follow-up of intensive glucose control in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Effects of intensive glucose lowering in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083508

29 October 2018

Identifiers

DOI

10.1056/NEJMOA1006524

1 reference

29 July 2017

1 reference

29 July 2017

1 reference